Show simple item record

dc.contributor.authorSturdy, Steve
dc.contributor.authorMiller, Fiona
dc.contributor.authorHogarth, Stuart
dc.contributor.authorArmstrong, Natalie
dc.contributor.authorChakraborty, Pranesh
dc.contributor.authorCressman, Celine
dc.contributor.authorDobrow, Mark
dc.contributor.authorFlitcroft, Kathy
dc.contributor.authorGrossman, David
dc.contributor.authorHarris, Russell
dc.contributor.authorHoebee, Barbara
dc.contributor.authorHolloway, Kelly
dc.contributor.authorKinsinger, Linda
dc.contributor.authorKrag, Marlene
dc.contributor.authorLöblová, Olga
dc.contributor.authorLöwy, Ilana
dc.contributor.authorMackie, Anne
dc.contributor.authorMarshall, John
dc.contributor.authorO'Hallahan, Jane
dc.contributor.authorRabeneck, Linda
dc.contributor.authorRaffle, Angela
dc.contributor.authorReid, Lynette
dc.contributor.authorShortland, Graham
dc.contributor.authorSteele, Robert
dc.contributor.authorTarini, Beth
dc.contributor.authorTaylor-Phillips, Sian
dc.contributor.authorTowler, Bernie
dc.contributor.authorvan der Veen, Nynke
dc.contributor.authorZappa, Marco
dc.date.accessioned2020-10-04T18:39:58Z
dc.date.available2020-10-04T18:39:58Z
dc.date.issued2020-01-01
dc.identifier.issn2398-502X
dc.identifier.pmid32923689
dc.identifier.doi10.12688/wellcomeopenres.16057.2
dc.identifier.urihttp://hdl.handle.net/10029/624419
dc.description.abstractBackground: In their landmark report on the "Principles and Practice of Screening for Disease" (1968), Wilson and Jungner noted that the practice of screening is just as important for securing beneficial outcomes and avoiding harms as the formulation of principles. Many jurisdictions have since established various kinds of "screening governance organizations" to provide oversight of screening practice. Yet to date there has been relatively little reflection on the nature and organization of screening governance itself, or on how different governance arrangements affect the way screening is implemented and perceived and the balance of benefits and harms it delivers. Methods: An international expert policy workshop convened by Sturdy, Miller and Hogarth. Results: While effective governance is essential to promote beneficial screening practices and avoid attendant harms, screening governance organizations face enduring challenges. These challenges are social and ethical as much as technical. Evidence-based adjudication of the benefits and harms of population screening must take account of factors that inform the production and interpretation of evidence, including the divergent professional, financial and personal commitments of stakeholders. Similarly, when planning and overseeing organized screening programs, screening governance organizations must persuade or compel multiple stakeholders to work together to a common end. Screening governance organizations in different jurisdictions vary widely in how they are constituted, how they relate to other interested organizations and actors, and what powers and authority they wield. Yet we know little about how these differences affect the way screening is implemented, and with what consequences. Conclusions: Systematic research into how screening governance is organized in different jurisdictions would facilitate policy learning to address enduring challenges. Even without such research, informal exchange and sharing of experiences between screening governance organizations can deliver invaluable insights into the social as well as the technical aspects of governance.en_US
dc.language.isoenen_US
dc.subjectgovernanceen_US
dc.subjectscreeningen_US
dc.titleHalf a Century of Wilson & Jungner: Reflections on the Governance of Population Screening.en_US
dc.typeArticleen_US
dc.identifier.journalWellcome Open Res 2020; 5:158en_US
dc.source.journaltitleWellcome open research


This item appears in the following Collection(s)

Show simple item record